Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Comment on: predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia.

Hermans SM, Sempa J, Castelnuovo B, Manabe YC, van Leth F.

Trans R Soc Trop Med Hyg. 2012 May;106(5):328-9. doi: 10.1016/j.trstmh.2012.02.004. Epub 2012 Mar 23. No abstract available.

PMID:
22445080
2.

Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia.

van Griensven J, Thai S.

Trans R Soc Trop Med Hyg. 2011 Dec;105(12):694-703. doi: 10.1016/j.trstmh.2011.08.007. Epub 2011 Oct 2.

PMID:
21962614
3.
4.

Limits to potent antiretroviral therapy.

Telenti A, Paolo Rizzardi G.

Rev Med Virol. 2000 Nov-Dec;10(6):385-93. Review.

PMID:
11114077
5.

Editorial comment: treatment of acute HIV infection--uncertainties about best practice.

Kassutto S, Rosenberg ES.

AIDS Read. 2005 May;15(5):250-1. No abstract available.

PMID:
15900635
6.

CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients: the role of intravenous drug use.

Dronda F, Zamora J, Moreno S, Moreno A, Casado JL, Muriel A, Pérez-Elías MJ, Antela A, Moreno L, Quereda C.

AIDS. 2004 Nov 5;18(16):2210-2.

PMID:
15577659
7.
8.

Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia.

Pujades-Rodríguez M, Schramm B, Som L, Nerrienet E, Narom P, Chanchhaya N, Ferradini L, Balkan S.

Trop Med Int Health. 2011 Feb;16(2):205-13. doi: 10.1111/j.1365-3156.2010.02689.x. Epub 2010 Nov 19.

9.

Immunological response to highly active antiretroviral therapy following treatment for prevention of mother to child transmission of HIV-1: a study in Côte d'Ivoire.

Ekouevi DK, Coffie PA, Chaix ML, Tonwe-Gold B, Amani-Bosse C, Leroy V, Abrams EJ, Dabis F.

J Int AIDS Soc. 2010 Aug 2;13:28. doi: 10.1186/1758-2652-13-28.

10.

Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3.

Seminari E, Tinelli C, Ravasi G, Ripamonti D, Ladisa N, Marino N, Sighinolfi L, Mondello P, Migliorino M, Carosi G, Maserati R; MASTER Cohort.

Curr HIV Res. 2010 Apr;8(3):186-93.

PMID:
20163342
11.

Onset of HIV-1 antibody production after highly active antiretroviral therapy in a seronegative HIV-1-infected child.

De Rossi A, Giaquinto C, Del Mistro A, Zamarchi R, Chieco-Bianchi L.

AIDS. 2000 Jun 16;14(9):1284-6. No abstract available.

PMID:
10894299
12.

HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.

Steingrover R, Pogány K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM.

AIDS. 2008 Aug 20;22(13):1583-8. doi: 10.1097/QAD.0b013e328305bd77.

PMID:
18670217
13.

Highly active antiretroviral therapy and beta-chemokines.

Brichacek B, Bukrinsky M.

Clin Exp Immunol. 2002 Nov;130(2):169-71. No abstract available.

14.
15.

Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.

Madec Y, Laureillard D, Pinoges L, Fernandez M, Prak N, Ngeth C, Moeung S, Song S, Balkan S, Ferradini L, Quillet C, Fontanet A.

AIDS. 2007 Jan 30;21(3):351-9.

PMID:
17255742
16.

Anti-human immunodeficiency virus type 1 humoral immune response and highly active antiretroviral treatment.

Bongertz V, Ouverney EP, Fernandez SC, Grinsztejn B, Veloso V, Couto-Fernandez JC, Pilotto JH, Morgado MG.

Mem Inst Oswaldo Cruz. 2007 Nov;102(7):817-25. Epub 2007 Dec 11.

17.

Immunological recovery after 3 years' antiretroviral therapy in HIV-1-infected children.

Resino S, Sanchez-Ramón S, Bellón JM, Correa R, Abad ML, Muñoz-Fernández MA.

AIDS. 2002 Feb 15;16(3):483-6. No abstract available.

PMID:
11834962
18.

HIV-1 reservoirs.

Pomerantz RJ.

Clin Lab Med. 2002 Sep;22(3):651-80, vi. Review.

PMID:
12244591
19.
20.

Immune restoration disease in HIV-infected patients after antiretroviral therapy.

French MA, Price P.

Clin Infect Dis. 2001 Jan 15;32(2):325-6. No abstract available.

PMID:
11170934

Supplemental Content

Support Center